We are live on
!
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Flex
FLEX
$36.4B
| $7.06M | 0.14% |
116,924
| – | – |
2024 Q3
6 quarters
|
|
127
Blackstone
BX
$87.1B
| $7.06M | 0.14% |
45,826
| – | – |
2022 Q1
16 quarters
|
|
128
Abbott
ABT
$181B
| $7.03M | 0.14% |
56,077
| – | – |
2022 Q1
16 quarters
|
|
129
iShares Russell 1000 ETF
IWB
$49.2B
| $6.96M | 0.14% |
18,637
| – | – |
2024 Q3
6 quarters
|
|
130
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.4B
| $6.9M | 0.14% |
184,474
| – | – |
2022 Q1
16 quarters
|
|
131
Vanguard High Dividend Yield ETF
VYM
$81.4B
| $6.89M | 0.14% |
48,002
| – | – |
2024 Q4
5 quarters
|
|
132
Schwab International Equity ETF
SCHF
$67B
| $6.87M | 0.13% |
285,716
| – | – |
2021 Q4
17 quarters
|
|
133
TJX Companies
TJX
$159B
| $6.83M | 0.13% |
44,440
| – | – |
2021 Q4
17 quarters
|
|
134
Dimensional Emerging Markets Value ETF
DFEV
$2.12B
| $6.76M | 0.13% |
200,501
| – | – |
2025 Q3
2 quarters
|
|
135
Eaton
ETN
$156B
| $6.75M | 0.13% |
21,178
| – | – |
2024 Q3
6 quarters
|
|
136
Altria Group
MO
$123B
| $6.51M | 0.13% |
112,883
| – | – |
2021 Q4
17 quarters
|
|
137
Citigroup
C
$207B
| $6.47M | 0.13% |
55,426
| – | – |
2022 Q2
15 quarters
|
|
138
Amgen
AMGN
$235B
| $6.38M | 0.13% |
19,503
| – | – |
2021 Q4
17 quarters
|
|
139
Dimensional US Core Equity Market ETF
DFAU
$13B
| $6.37M | 0.13% |
136,017
| – | – |
2025 Q3
2 quarters
|
|
140
GE Vernova
GEV
$247B
| $6.28M | 0.12% |
9,613
| – | – |
2024 Q3
6 quarters
|
|
141
iShares US Equity Factor ETF
LRGF
$3.73B
| $6.23M | 0.12% |
89,776
| – | – |
2025 Q2
3 quarters
|
|
142
McDonald's
MCD
$172B
| $6.16M | 0.12% |
20,153
| – | – |
2022 Q3
14 quarters
|
|
143
Booking.com
BKNG
$125B
| $6.15M | 0.12% |
28,700
| – | – |
2022 Q1
16 quarters
|
|
144
HCA Healthcare
HCA
$101B
| $6.07M | 0.12% |
12,998
| – | – |
2024 Q3
6 quarters
|
|
145
Schwab US TIPS ETF
SCHP
$16.3B
| $5.93M | 0.12% |
223,779
| – | – |
2022 Q1
16 quarters
|
|
146
ICICI Bank
IBN
$106B
| $5.91M | 0.12% |
198,241
| – | – |
2024 Q3
6 quarters
|
|
147
NextEra Energy
NEE
$165B
| $5.88M | 0.12% |
73,209
| – | – |
2022 Q3
14 quarters
|
|
148
Lowe's Companies
LOW
$110B
| $5.82M | 0.11% |
24,128
| – | – |
2021 Q4
17 quarters
|
|
149
Gilead Sciences
GILD
$195B
| $5.71M | 0.11% |
46,492
| – | – |
2022 Q1
16 quarters
|
|
150
iShares Core International Aggregate Bond Fund
IAGG
$12.5B
| $5.7M | 0.11% |
113,892
| – | – |
2022 Q2
15 quarters
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.